Ani Pharmaceuticals Stock Volatility

ANIP Stock  USD 65.43  0.71  1.07%   
ANI Pharmaceuticals appears to be very steady, given 3 months investment horizon. ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of return volatility over the last 3 months. We have found thirty technical indicators for ANI Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of ANI Pharmaceuticals' Risk Adjusted Performance of 0.0942, mean deviation of 1.32, and Semi Deviation of 1.23 to double-check if our risk estimates are consistent with your expectations. Key indicators related to ANI Pharmaceuticals' volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
ANI Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of ANI daily returns, and it is calculated using variance and standard deviation. We also use ANI's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of ANI Pharmaceuticals volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as ANI Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of ANI Pharmaceuticals at lower prices. For example, an investor can purchase ANI stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of ANI Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with ANI Stock

  0.9VKTX Viking Therapeutics Potential GrowthPairCorr
  0.94ELEV Elevation Oncology Earnings Call Next WeekPairCorr
  0.64BMY Bristol Myers Squibb Earnings Call TomorrowPairCorr
  0.73XFOR X4 Pharmaceuticals Earnings Call Next WeekPairCorr

Moving against ANI Stock

  0.69ZURA Zura Bio Limited Financial Report 10th of May 2024 PairCorr
  0.58GILD Gilead Sciences Earnings Call TomorrowPairCorr

ANI Pharmaceuticals Market Sensitivity And Downside Risk

ANI Pharmaceuticals' beta coefficient measures the volatility of ANI stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents ANI stock's returns against your selected market. In other words, ANI Pharmaceuticals's beta of 0.81 provides an investor with an approximation of how much risk ANI Pharmaceuticals stock can potentially add to one of your existing portfolios. ANI Pharmaceuticals has relatively low volatility with skewness of 2.96 and kurtosis of 16.69. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ANI Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ANI Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze ANI Pharmaceuticals Demand Trend
Check current 90 days ANI Pharmaceuticals correlation with market (NYSE Composite)

ANI Beta

    
  0.81  
ANI standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  2.07  
It is essential to understand the difference between upside risk (as represented by ANI Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of ANI Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in ani stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in ANI Pharmaceuticals.

Using ANI Put Option to Manage Risk

Put options written on ANI Pharmaceuticals grant holders of the option the right to sell a specified amount of ANI Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of ANI Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge ANI Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding ANI Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.

ANI Pharmaceuticals' PUT expiring on 2024-05-17

   Profit   
       ANI Pharmaceuticals Price At Expiration  

Current ANI Pharmaceuticals Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2024-05-17 PUT at $70.0-0.7150.050212024-05-173.3 - 7.74.76View
Put
2024-05-17 PUT at $65.0-0.44070.055330102024-05-170.85 - 2.92.51View
View All ANI Pharmaceuticals Options

ANI Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which ANI Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with ANI Pharmaceuticals' price changes. Investors will then calculate the volatility of ANI Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of ANI Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures ANI Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict ANI Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for ANI Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on ANI Pharmaceuticals' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. ANI Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

ANI Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days ANI Pharmaceuticals has a beta of 0.8075 . This suggests as returns on the market go up, ANI Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ANI Pharmaceuticals will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ANI Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ANI Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ANI stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
ANI Pharmaceuticals has an alpha of 0.2098, implying that it can generate a 0.21 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
ANI Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how ani stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an ANI Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

ANI Pharmaceuticals Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of ANI Pharmaceuticals is 653.73. The daily returns are distributed with a variance of 4.28 and standard deviation of 2.07. The mean deviation of ANI Pharmaceuticals is currently at 1.3. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α
Alpha over NYSE Composite
0.21
β
Beta against NYSE Composite0.81
σ
Overall volatility
2.07
Ir
Information ratio 0.09

ANI Pharmaceuticals Stock Return Volatility

ANI Pharmaceuticals historical daily return volatility represents how much of ANI Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 2.0699% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.633% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About ANI Pharmaceuticals Volatility

Volatility is a rate at which the price of ANI Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of ANI Pharmaceuticals may increase or decrease. In other words, similar to ANI's beta indicator, it measures the risk of ANI Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of ANI Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Market Cap473.1 M496.8 M
ANI Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on ANI Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much ANI Pharmaceuticals' price varies over time.

3 ways to utilize ANI Pharmaceuticals' volatility to invest better

Higher ANI Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of ANI Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. ANI Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of ANI Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in ANI Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of ANI Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

ANI Pharmaceuticals Investment Opportunity

ANI Pharmaceuticals has a volatility of 2.07 and is 3.29 times more volatile than NYSE Composite. 18 percent of all equities and portfolios are less risky than ANI Pharmaceuticals. You can use ANI Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of ANI Pharmaceuticals to be traded at $63.47 in 90 days.

Modest diversification

The correlation between ANI Pharmaceuticals and NYA is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.

ANI Pharmaceuticals Additional Risk Indicators

The analysis of ANI Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in ANI Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of ANI Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

ANI Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against ANI Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. ANI Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, ANI Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to ANI Pharmaceuticals.
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for ANI Stock analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
0.85
Revenue Per Share
27.044
Quarterly Revenue Growth
0.397
Return On Assets
0.0372
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.